Free Trial
NYSE:HCA

HCA Healthcare (HCA) Stock Price, News & Analysis

HCA Healthcare logo
$321.99 +2.36 (+0.74%)
Closing price 03:59 PM Eastern
Extended Trading
$318.12 -3.87 (-1.20%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About HCA Healthcare Stock (NYSE:HCA)

Key Stats

Today's Range
$317.38
$322.68
50-Day Range
$296.45
$336.93
52-Week Range
$289.98
$417.14
Volume
1.51 million shs
Average Volume
1.71 million shs
Market Capitalization
$79.96 billion
P/E Ratio
14.66
Dividend Yield
0.89%
Price Target
$385.67
Consensus Rating
Moderate Buy

Company Overview

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
97th Percentile Overall Score

HCA MarketRank™: 

HCA Healthcare scored higher than 97% of companies evaluated by MarketBeat, and ranked 24th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HCA Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 12 buy ratings, 3 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    HCA Healthcare has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about HCA Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for HCA Healthcare are expected to grow by 12.21% in the coming year, from $24.98 to $28.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HCA Healthcare is 14.66, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.63.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HCA Healthcare is 14.66, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 24.97.

  • Price to Earnings Growth Ratio

    HCA Healthcare has a PEG Ratio of 1.10. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    HCA Healthcare has a P/B Ratio of 144.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about HCA Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    3.40% of the float of HCA Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    HCA Healthcare has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCA Healthcare has recently increased by 13.32%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    HCA Healthcare has a dividend yield of 0.82%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    HCA Healthcare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of HCA Healthcare is 13.11%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, HCA Healthcare will have a dividend payout ratio of 10.27% next year. This indicates that HCA Healthcare will be able to sustain or increase its dividend.

  • Read more about HCA Healthcare's dividend.
  • Percentage of Shares Shorted

    3.40% of the float of HCA Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    HCA Healthcare has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCA Healthcare has recently increased by 13.32%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    HCA Healthcare has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 28 news articles for HCA Healthcare this week, compared to 18 articles on an average week.
  • Search Interest

    Only 15 people have searched for HCA on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • MarketBeat Follows

    Only 8 people have added HCA Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HCA Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,075,250.00 in company stock.

  • Percentage Held by Insiders

    Only 1.60% of the stock of HCA Healthcare is held by insiders.

  • Percentage Held by Institutions

    62.73% of the stock of HCA Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about HCA Healthcare's insider trading history.
Receive HCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HCA Healthcare and its competitors with MarketBeat's FREE daily newsletter.

HCA Stock News Headlines

New Way To Target 2x Trades Every Monday Morning
No. 1 Stock to Buy for THIS MONDAY Heads up: Tim Bohen’s new algorithm just uncovered a dirt-cheap stock that could DOUBLE or MORE this coming Monday. This powerful algo has already identified Monday moves of 149%, 190%, and even a whopping 536%...
TD Cowen Keeps Their Buy Rating on HCA Healthcare (HCA)
See More Headlines

HCA Stock Analysis - Frequently Asked Questions

HCA Healthcare's stock was trading at $300.15 at the beginning of 2025. Since then, HCA stock has increased by 7.3% and is now trading at $321.9880.
View the best growth stocks for 2025 here
.

HCA Healthcare, Inc. (NYSE:HCA) released its quarterly earnings results on Friday, January, 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a trailing twelve-month return on equity of 586.47% and a net margin of 8.16%.
Read the conference call transcript
.

HCA Healthcare's Board of Directors initiated a share repurchase program on Tuesday, January 30th 2024, which allows the company to buy back $6,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 7.4% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board of directors believes its shares are undervalued.

HCA Healthcare subsidiaries include Valify, Galen College of Nursing, Mission Health, Highlands Regional Medical Center, Weatherford Regional Medical Center, Memorial University Medical Center, Mobile Heartbeat, and more.

Top institutional shareholders of HCA Healthcare include Vanguard Group Inc. (6.25%), Sanders Capital LLC (4.60%), Wellington Management Group LLP (2.55%) and First Eagle Investment Management LLC (1.78%). Insiders that own company stock include Thomas F Frist Jr, Charles J Hall, Patricia F Elcan, Bill B Rutherford, Phillip G Billington, Christopher F Wyatt, A Bruce Moore Jr, Michael S Cuffe, P Martin Paslick, Kathryn A Torres, Jennifer Berres, Timothy M Mcmanus, Jon M Foster, Kathleen M Whalen, Sammie S Mosier, Erol R Akdamar, Jeffrey E Cohen, Andrea B Smith, Chad J Wasserman, Michael R Mcalevey, Deborah M Reiner and Joseph A Sowell III.
View institutional ownership trends
.

Shares of HCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HCA Healthcare investors own include Chevron (CVX), Bristol-Myers Squibb (BMY), Comcast (CMCSA), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

Ex-Dividend for 12/27 Dividend
12/13/2024
Dividend Payable
12/27/2024
Last Earnings
1/24/2025
Today
3/06/2025
Ex-Dividend for 3/31 Dividend
3/17/2025
Dividend Payable
3/31/2025
Next Earnings (Estimated)
4/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
Health Care Facilities
Current Symbol
NYSE:HCA
Employees
294,000
Year Founded
1968

Price Target and Rating

Average Stock Price Target
$385.67
High Stock Price Target
$440.00
Low Stock Price Target
$320.00
Potential Upside/Downside
+19.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
18 Analysts

Profitability

Trailing P/E Ratio
14.66
Forward P/E Ratio
12.89
P/E Growth
1.1
Net Income
$5.76 billion
Pretax Margin
12.07%

Debt

Sales & Book Value

Annual Sales
$70.60 billion
Cash Flow
$35.98 per share
Price / Cash Flow
8.95
Book Value
$2.23 per share
Price / Book
144.39

Miscellaneous

Free Float
244,369,000
Market Cap
$79.96 billion
Optionable
Optionable
Beta
1.64

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NYSE:HCA) was last updated on 3/6/2025 by MarketBeat.com Staff
From Our Partners